Benefit brokers have long competed for employer-based group health insurance business in part by touting their ability to “get the best deal” for their clients. Brokers often point to their size (large or small), geographic location or an influential relationship with an insurance company to support their claim of being able to secure a better rate than a competitor.

Gone are the days when placing employer-based health insurance coverage involved a relatively simple transaction between an employer and its benefit broker. The Patient Protection and Affordable Care Act (PPACA) significantly complicated the landscape for employer-based health insurance, including imposing stringent new compliance mandates on employers. In an effort to manage this risk, employers and human resource (HR) departments are demanding more services from their brokers.

Private healthcare payers have faced significant cost pressures for years and are now confronted with the recent changes to the healthcare system. With challenges such as the rise of complex payment systems, transformation from the B2B to B2C market and the addition of millions of beneficiaries who are likely to choose plans that reimburse at the lowest rates, the need for cost containment is more urgent today than ever.

As competition across the private equity market continues to heat up and funds look for their next actionable win, procurement optimization remains one of the most tangible value drivers to quickly boost operational performance within portfolio companies.

Working capital adjustments are often some of the most highly negotiated provisions in a private company M&A transaction agreement.

In this, the era of “Re-Globalization”, geopolitical and macroeconomic risks are becoming increasingly influential on investment, both within and between countries.

Commercial Due Diligence (CDD) Offerings

Steering companies through the economic turbulence of the past five years has placed extraordinary pressure on chief executives. Many have taken their organisations to higher levels of performance while others have been replaced by those better equipped for these times. Uncertainty persists in the UK, Eurozone, and the global financial markets which suggests there are many more challenges and opportunities to come.

At first glance, acquiring an S corporation is a seemingly innocuous event; after all, S corporations are “flow-through” entities that generally are not subject to income taxes. Instead, income, losses, deductions and credits all flow through to the shareholders and are reported on the shareholders’ respective federal income tax returns.

Discover what distinguishes exceptional chairmen from their peers in today’s turbulent economy. This report is based on the collective insights of 22 current and past chairmen, most of whom chair FTSE 100 and 250 companies, who have drawn on their experiences of working with over 120 chairmen in their careers.

A global digital revolution across industries is being driven by consumers’ increased access to technology
and the omni-availability of the internet.

Mergers and acquisitions continue to flourish within the pharmaceutical industry. Are multinational pharmaceutical enterprises still able to generate tax savings through IP migration to Ireland, in light of the OECD action plan to combat base erosion and profit shifting?

In the current oil and gas environment, many companies need the support of experienced professionals who can work alongside management to deliver solutions to complex problems.

A&M helps our financial services clients stay ahead of the most pressing issues of the day. Whether you are looking
to manage regulatory and compliance risk, maximize the value of your technology investments, enhance cybersecurity
defenses, unlock value in underperforming assets or improve the customer experience, A&M can help.